NGSサンプル調製市場 : 2028年までの世界予測

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2023年3月

NGSサンプル調製市場 : 製品（試薬と消耗品、ワークステーション）、ワークフロー（ライブラリー調製、ターゲット濃縮）、サンプルタイプ（DNA）、用途（診断、創薬）、方法（マイクロフルイディック、自動化）、エンドユーザーと地域別 – 2028年までの世界予測
NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (Library Prep, Target Enrichment), Sample Type (DNA), Application (Diagnostics, Drug Discovery), Method (Microfluidic, Automated), End User & Region – Global Forecast to 2028

レポート目次　　　　お問合せ・ご注文　　　　価格・納期について

The NGS sample preparation market is projected to reach USD 4.0 billion by 2028 from USD 1.9 billion in 2022, at a CAGR of 13.4% during the forecast period. The key factors driving the growth of the NGS sample preparation market are constant innovations in NGS platforms, and increased availability of advanced NGS systems at low costs. However, the presence of alternative technologies is expected to restrain market growth to a certain extent.

The NGS sample preparation market has been segmented based on products & services, workflow, sample type, method, application, end user, and region.
“By application, the disease diagnostics accounted for the largest share of the NGS sample preparation market”
Based on application, the NGS sample preparation market is categorized into disease diagnostics, drug discovery, agricultural & animal research, and others. The disease diagnostics segment dominated the market in 2022, owing to favorable reimbursement scenario for NGS-based tests and increasing focus of key players on developing NGS-based products & services for cancer and NIPT are the key factors driving the growth of the segment.
“By end user, the academic institutes & research centers accounted for the largest share in the NGS Sample Preparation market”
Based on end user, the NGS sample preparation market is segmented into hospitals & clinics, academic institutes & research centers, pharmaceutical & biotechnology companies, and other end users. In 2022, the academic institutes & research centers segment accounted for a larger share of the NGS sample preparation market. Growth in this market segment can be attributed to availability of financial support for genomics R&D across regions, and the development of cost-effective NGS products & services for researchers.

“North America: the largest share of the NGS sample preparation market”
North America accounted for the largest share of the NGS sample preparation market. Favorable initiatives by government and private bodies for the adoption of NGS technologies, advancements in NGS sample preparation products, the growing prevalence of target diseases, an increasing number of NGS-based research & clinical applications, growing research on cancer, the rising awareness of NGS services, and the presence of leading NGS service providers, such as Illumina (US), Thermo Fisher Scientific (US), and Agilent Technologies (US), are driving the growth of the NGS sample preparation market in North America.
“Asia Pacific: The fastest-growing region in the NGS sample preparation market.”
The Asia Pacific NGS sample preparation market is projected to grow at the highest CAGR during the forecast period, mainly due to significant focus on R&D activities as a means of broadening the scope of NGS applications, the increasing adoption of NGS for diagnostics due to the decreasing cost of NGS products and services, and technological development in NGS data analysis. In addition, a number of domestic and international market players focus on strengthening their presence in the Asia Pacific NGS market, while domestic players expand their international reach through partnerships, collaborations, agreements, and expansions.
The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 60% and Demand Side 40%
• By Designation: Executives – 40%, Research Scientists- 30%, and Managers – 30%
• By Country: North America- 22%, Europe- 42%, Asia Pacific- 11%, Latin America- 20%, and MEA- 5%

Prominent Players
• Illumina, Inc. (US)
• Thermo Fisher Scientific Inc. (US)
• PerkinElmer Inc. (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Agilent Technologies, Inc. (US)
• Danaher (US)
• Becton, Dickinson and Company (US)
• Merck KGAA (Germany)
• QIAGEN (Germany)
• Bio-Rad Laboratories, Inc. (US)
• Promega Corporation (US)
• Eurofins Scientific (Luxembourg)
• BGI (China)
• 10x Genomics (US)
• Sysmex Corporation (US)
• Psomagen (US)
• Zymo Research Corporation (US)
• Takara Bio Inc. (Japan)
• Novogene Co., Ltd. (China)
• New England Biolabs (US)
• Tecan Trading AG (US)
• Oxford Nanopore Technologies PLC (UK)
• PacBio (US)
• Medgenome (US)
• Swift Biosciences Inc. (US)

Research Coverage:
This report provides a detailed picture of the NGS sample preparation market. It aims at estimating the size and future growth potential of the market across different segments, such as the product & services, workflow, sample type, method, applications, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NGS sample preparation market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

目次

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.2.1 INCLUSIONS AND EXCLUSIONS 41
1.3 STUDY SCOPE 42
1.4 YEARS CONSIDERED 43
1.5 CURRENCY CONSIDERED 43
1.6 RESEARCH LIMITATIONS 43
1.7 STAKEHOLDERS 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 1 RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 44
2.1.2 PRIMARY DATA 45
FIGURE 2 BREAKDOWN OF PRIMARIES 46
2.2 MARKET ESTIMATION METHODOLOGY 46
FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS), 2021 47
FIGURE 4 NGS SAMPLE PREPARATION MARKET SIZE (USD MILLION) 48
FIGURE 5 NGS SAMPLE PREPARATION MARKET: FINAL CAGR PROJECTIONS (2023−2028) 48
FIGURE 6 NGS SAMPLE PREPARATION MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
2.3 MARKET DATA ESTIMATION AND TRIANGULATION 50
FIGURE 7 DATA TRIANGULATION METHODOLOGY 50
2.4 INDUSTRY INSIGHTS 51
2.5 STUDY ASSUMPTIONS 51
2.6 GLOBAL RECESSION IMPACT: NGS SAMPLE PREPARATION MARKET 51
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 52
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 52
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 52
3 EXECUTIVE SUMMARY 54
FIGURE 8 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2022 VS. 2028 (USD MILLION) 54
FIGURE 9 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2022 VS. 2028 (USD MILLION) 55
FIGURE 10 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2022 VS. 2028 (USD MILLION) 55
FIGURE 11 NGS SAMPLE PREPARATION MARKET, BY METHOD, 2022 VS. 2028 (USD MILLION) 56
FIGURE 12 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2022 VS. 2028 (USD MILLION) 57
FIGURE 13 NGS SAMPLE PREPARATION MARKET, BY END USER, 2022 VS. 2028 (USD MILLION) 57
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF NGS SAMPLE PREPARATION MARKET 58
4 PREMIUM INSIGHTS 59
4.1 NGS SAMPLE PREPARATION MARKET OVERVIEW 59
FIGURE 15 ADVANCEMENTS IN NGS PLATFORMS TO DRIVE GROWTH 59
4.2 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022) 60
FIGURE 16 REAGENTS & CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 60
4.3 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2022 VS. 2028 60
FIGURE 17 DISEASE DIAGNOSTICS SEGMENT TO DOMINATE MARKET IN 2028 60
4.4 NGS SAMPLE PREPARATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 62
FIGURE 19 NGS SAMPLE PREPARATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62
TABLE 4 NGS SAMPLE PREPARATION MARKET: IMPACT ANALYSIS 63
5.2.1 DRIVERS 63
5.2.1.1 Constant innovations in NGS platforms 63
5.2.1.2 Increased availability of advanced NGS systems at low costs 64
FIGURE 20 COST PER HUMAN GENOME, 2001–2021 64
5.2.1.3 Use of NGS as substitute for PCR 65
5.2.1.4 Greater efficiency of genotyping and preparation protocols 65
5.2.2 RESTRAINTS 65
5.2.2.1 Presence of alternative technologies 65
5.2.2.2 Limited expertise and sequencing capabilities of individual laboratories 65
5.2.3 OPPORTUNITIES 66
5.2.3.1 Increasing collaborations and partnerships among key players 66
5.2.4 CHALLENGES 66
5.2.4.1 Ethical and privacy issues in health data 66
5.3 TECHNOLOGY ANALYSIS 67
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
5.5 SUPPLY AND VALUE CHAIN ANALYSIS 68
5.5.1 SUPPLY CHAIN ANALYSIS OF NGS SAMPLE PREPARATION MARKET 68
FIGURE 22 NGS SAMPLE PREPARATION MARKET: SUPPLY CHAIN ANALYSIS 69
5.5.2 VALUE CHAIN ANALYSIS OF NGS SAMPLE PREPARATION MARKET 69
FIGURE 23 NGS SAMPLE PREPARATION MARKET: VALUE CHAIN ANALYSIS 69
5.6 ECOSYSTEM ANALYSIS 70
FIGURE 24 NGS SAMPLE PREPARATION MARKET: ECOSYSTEM ANALYSIS 70
5.7 PORTER’S FIVE FORCES ANALYSIS 71
TABLE 5 NGS SAMPLE PREPARATION MARKET: PORTER’S FIVE FORCES ANALYSIS 71
5.7.1 THREAT OF NEW ENTRANTS 71
5.7.2 THREAT OF SUBSTITUTES 71
5.7.3 BARGAINING POWER OF BUYERS 71
5.7.4 BARGAINING POWER OF SUPPLIERS 72
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 72
5.8 REGULATORY ANALYSIS 72
5.8.1 FDA APPROVALS 72
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 7 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 8 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
5.9 PRICING ANALYSIS 75
TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT 75
5.9.1 AVERAGE SELLING PRICE TREND ANALYSIS 76
5.10 PATENT ANALYSIS 76
FIGURE 25 PATENT FILING TRENDS FOR TOP 5 IPC MAIN CLASSES, 2018−2020 76
5.11 KEY CONFERENCES AND EVENTS IN 2023 77
5.11.1 CONFERENCES ON NGS SAMPLE PREPARATION IN 2023 77
TABLE 11 CONFERENCES ON NGS SAMPLE PREPARATION (2023) 77
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 77
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 77
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN NGS SAMPLE PREPARATION MARKET 77
5.12.2 BUYING CRITERIA FOR NGS SAMPLE PREPARATION MARKET 78
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 78

6 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE 79
6.1 INTRODUCTION 80
TABLE 12 NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 80
6.2 WORKSTATIONS/INSTRUMENTS 80
6.2.1 INCREASING DEMAND FOR AUTOMATION OF NGS TO PROPEL MARKET 80
TABLE 13 NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 14 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 15 EUROPE: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 16 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 17 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR WORKSTATIONS/INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 83
6.3 REAGENTS & CONSUMABLES 83
6.3.1 GROWING USE OF CONSUMABLES FOR NGS SAMPLE PREPARATION TO DRIVE MARKET 83
TABLE 18 NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2021–2028 (USD MILLION) 84
TABLE 19 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 20 EUROPE: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 21 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 22 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 85
6.4 SERVICES 85
6.4.1 INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT MARKET 85
TABLE 23 NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 24 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 25 EUROPE: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 26 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 27 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 88

7 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW 89
7.1 INTRODUCTION 90
TABLE 28 NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 90
7.2 DNA FRAGMENTATION & LIBRARY PREPARATION 90
7.2.1 AVAILABILITY OF PRODUCTS FROM VARIOUS PLAYERS TO DRIVE MARKET 90
TABLE 29 NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 30 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 31 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 32 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 33 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA FRAGMENTATION & LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 93
7.3 TARGET ENRICHMENT 93
7.3.1 LAUNCH OF ADVANCED TARGET ENRICHMENT SOLUTIONS AND TECHNOLOGIES TO DRIVE MARKET 93
TABLE 34 NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 35 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 36 EUROPE: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 37 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 38 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR TARGET ENRICHMENT, BY COUNTRY, 2021–2028 (USD MILLION) 95
7.4 QUALITY CONTROL 95
7.4.1 RISING NUMBER OF RESEARCH ACTIVITIES REQUIRING QUALITY-ASSURED SAMPLES TO PROPEL MARKET 95
TABLE 39 NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY REGION, 2021–2028 (USD MILLION) 96
TABLE 40 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 41 EUROPE: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 42 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 43 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR QUALITY CONTROL, BY COUNTRY, 2021–2028 (USD MILLION) 97

8 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE 98
8.1 INTRODUCTION 99
TABLE 44 NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 99
8.2 DNA 99
8.2.1 RISING NUMBER OF CANCER CASES AND GROWING R&D INVESTMENTS FOR STUDYING DNA SAMPLES TO DRIVE MARKET 99
TABLE 45 NGS SAMPLE PREPARATION MARKET FOR DNA, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 46 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 47 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 48 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 49 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DNA, BY COUNTRY, 2021–2028 (USD MILLION) 101
8.3 RNA 101
8.3.1 DECREASED COSTS OF GENOME SEQUENCING TO AUGMENT MARKET 101
TABLE 50 NGS SAMPLE PREPARATION MARKET FOR RNA, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 51 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 52 EUROPE: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 53 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 54 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR RNA, BY COUNTRY, 2021–2028 (USD MILLION) 103
9 NGS SAMPLE PREPARATION MARKET, BY APPLICATION 104
9.1 INTRODUCTION 105
TABLE 55 NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 105
9.2 DISEASE DIAGNOSTICS 105
TABLE 56 NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 57 NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 58 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 59 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 60 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 61 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 108
9.2.1 CANCER DIAGNOSTICS 108
9.2.1.1 Increase in cancer patients globally and launch of NGS-based cancer panels to drive market 108
TABLE 62 CANCER DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION) 109
TABLE 63 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 64 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 65 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 66 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
9.2.2 REPRODUCTIVE HEALTH DIAGNOSTICS 110
9.2.2.1 Increasing awareness about benefits of NIPT and decreasing costs of sequencing to propel market 110
TABLE 67 REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 68 NORTH AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 69 EUROPE: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 70 ASIA PACIFIC: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 71 LATIN AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
9.2.3 INFECTIOUS DISEASE DIAGNOSTICS 113
9.2.3.1 Growing burden of healthcare-associated infections to aid market 113
TABLE 72 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 73 NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 74 EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 75 ASIA PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 76 LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
9.2.4 OTHER DISEASE DIAGNOSTIC APPLICATIONS 115
TABLE 77 OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 78 NORTH AMERICA: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 79 EUROPE: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 80 ASIA PACIFIC: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 81 LATIN AMERICA: OTHER DISEASE DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
9.3 DRUG DISCOVERY 117
9.3.1 INCREASING USE OF NGS DURING CLINICAL TRIALS TO AUGMENT MARKET 117
TABLE 82 NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION) 118
TABLE 83 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 84 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 85 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 86 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 120
9.4 AGRICULTURAL & ANIMAL RESEARCH 120
9.4.1 INCREASED FUNDING AND SUPPORT FOR ANIMAL AND PLANT GENOMICS RESEARCH TO FUEL ADOPTION 120
TABLE 87 NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 88 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 89 EUROPE: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 90 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 91 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR AGRICULTURAL & ANIMAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 122
9.5 OTHER APPLICATIONS 122
TABLE 92 NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 93 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 94 EUROPE: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 95 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 96 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 124
10 NGS SAMPLE PREPARATION MARKET, BY METHOD 125
10.1 INTRODUCTION 126
TABLE 97 NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 126
10.2 MANUAL SAMPLE PREPARATION 126
10.2.1 ERRORS ASSOCIATED WITH NGS MANUAL SAMPLE PREPARATION TO HINDER MARKET 126
TABLE 98 NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION) 127
TABLE 99 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 100 EUROPE: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 101 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 102 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR MANUAL SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 128
10.3 MICROFLUIDIC SAMPLE PREPARATION 128
10.3.1 GROWING APPLICATIONS OF MICROFLUIDIC SAMPLE PREPARATION TO CREATE OPPORTUNITIES 128
TABLE 103 NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 104 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 105 EUROPE: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 106 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 107 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR MICROFLUIDIC SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 131
10.4 AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION 131
10.4.1 HIGH PERFORMANCE AND ACCURACY OF AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION TO BOOST GROWTH 131
TABLE 108 NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 109 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 110 EUROPE: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 111 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 112 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR AUTOMATED LIQUID HANDLING-BASED SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 133
11 NGS SAMPLE PREPARATION MARKET, BY END USER 134
11.1 INTRODUCTION 135
TABLE 113 NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 135
11.2 HOSPITALS & CLINICS 135
11.2.1 ADVANTAGES OF NGS TECHNOLOGY FOR DISEASE DIAGNOSIS OVER CONVENTIONAL METHOD TO FUEL ADOPTION 135
TABLE 114 NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 115 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 116 EUROPE: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 117 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 118 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 138
11.3 ACADEMIC INSTITUTES & RESEARCH CENTERS 138
11.3.1 AVAILABILITY OF FINANCIAL SUPPORT FOR GENOMICS RESEARCH TO SUPPORT SEGMENT 138
TABLE 119 NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 120 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 121 EUROPE: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 122 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 123 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR ACADEMIC INSTITUTES & RESEARCH CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 141
11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 141
11.4.1 GROWING COLLABORATIONS BETWEEN NGS MARKET PLAYERS AND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE GROWTH 141
TABLE 124 NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 142
TABLE 125 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 126 EUROPE: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 127 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 128 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 144
11.5 OTHER END USERS 144
TABLE 129 NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 144
TABLE 130 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 131 EUROPE: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 132 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 133 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 146

12 NGS SAMPLE PREPARATION MARKET, BY REGION 147
12.1 INTRODUCTION 148
FIGURE 28 NGS SAMPLE PREPARATION MARKET, BY REGION, 2021 VS. 2028 (USD MILLION) 148
TABLE 134 NGS SAMPLE PREPARATION MARKET, BY REGION, 2021–2028 (USD MILLION) 149
12.2 NORTH AMERICA 149
FIGURE 29 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET SNAPSHOT 150
TABLE 135 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 136 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 151
TABLE 137 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 151
TABLE 138 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 151
TABLE 139 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 152
TABLE 140 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 152
TABLE 141 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 153
TABLE 142 NORTH AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 153
12.2.1 US 153
12.2.1.1 Favorable regulatory and reimbursement scenarios to drive market 153
TABLE 143 US: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 154
TABLE 144 US: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 154
TABLE 145 US: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 155
TABLE 146 US: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 155
TABLE 147 US: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 148 US: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 149 US: NGS SAMPLE PREPARATION MARKET BY END USER, 2021–2028 (USD MILLION) 156
12.2.2 CANADA 156
12.2.2.1 Favorable government funding to boost genomics research 156
TABLE 150 CANADA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 157
TABLE 151 CANADA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 157
TABLE 152 CANADA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 158
TABLE 153 CANADA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 158
TABLE 154 CANADA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 158
TABLE 155 CANADA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 156 CANADA: NGS SAMPLE PREPARATION MARKET, FOR END USER, 2021–2028 (USD MILLION) 159
12.2.3 NORTH AMERICA: IMPACT OF RECESSION 159
12.3 EUROPE 160
TABLE 157 EUROPE: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 158 EUROPE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 161
TABLE 159 EUROPE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 161
TABLE 160 EUROPE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 161
TABLE 161 EUROPE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 162
TABLE 162 EUROPE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 162
TABLE 163 EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 164 EUROPE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 163
12.3.1 GERMANY 163
12.3.1.1 Strong R&D base and presence of several NGS players to support market 163
TABLE 165 GERMANY: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 164
TABLE 166 GERMANY: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 165
TABLE 167 GERMANY: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 165
TABLE 168 GERMANY: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 166
TABLE 169 GERMANY: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166
TABLE 170 GERMANY: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 171 GERMANY: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 167
12.3.2 UK 167
12.3.2.1 Use of NGS-based tests for disease diagnosis to augment market 167
TABLE 172 UK: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 168
TABLE 173 UK: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 169
TABLE 174 UK NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 169
TABLE 175 UK NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 169
TABLE 176 UK: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 170
TABLE 177 UK: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 178 UK: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 171
12.3.3 FRANCE 171
12.3.3.1 Growing government support for genomics research to propel market 171
TABLE 179 FRANCE: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 172
TABLE 180 FRANCE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 172
TABLE 181 FRANCE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 173
TABLE 182 FRANCE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 173
TABLE 183 FRANCE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 184 FRANCE: NGS SAMPLE PREPARATION MARKET BY DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 185 FRANCE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 174
12.3.4 REST OF EUROPE 174
TABLE 186 REST OF EUROPE NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 175
TABLE 187 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 175
TABLE 188 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 176
TABLE 189 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 176
TABLE 190 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 191 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 192 REST OF EUROPE: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 178
12.3.5 EUROPE: IMPACT OF RECESSION 178
12.4 ASIA PACIFIC 178
FIGURE 30 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET SNAPSHOT 179
TABLE 193 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 194 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 180
TABLE 195 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 181
TABLE 196 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 181
TABLE 197 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 182
TABLE 198 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 199 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 200 ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 183
12.4.1 CHINA 184
12.4.1.1 Favorable government initiatives for advanced life science research to aid market 184
TABLE 201 CHINA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 184
TABLE 202 CHINA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 185
TABLE 203 CHINA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 185
TABLE 204 CHINA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 185
TABLE 205 CHINA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 186
TABLE 206 CHINA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 207 CHINA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 187
12.4.2 JAPAN 187
12.4.2.1 Increased research funding to create growth opportunities for NGS-based studies 187
TABLE 208 JAPAN: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 187
TABLE 209 JAPAN: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 188
TABLE 210 JAPAN: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 188
TABLE 211 JAPAN: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 188
TABLE 212 JAPAN: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 189
TABLE 213 JAPAN: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 214 JAPAN: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 190
12.4.3 INDIA 190
12.4.3.1 Decreasing sequencing costs and growing prevalence of target diseases to support market 190
TABLE 215 INDIA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 191
TABLE 216 INDIA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 191
TABLE 217 INDIA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 191
TABLE 218 INDIA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 192
TABLE 219 INDIA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192
TABLE 220 INDIA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 221 INDIA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 193
12.4.4 AUSTRALIA 193
12.4.4.1 Increasing use of NGS platforms by academic institutes to propel market 193
TABLE 222 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 194
TABLE 223 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 194
TABLE 224 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 195
TABLE 225 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 195
TABLE 226 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 195
TABLE 227 AUSTRALIA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 228 AUSTRALIA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 196
12.4.5 SOUTH KOREA 196
12.4.5.1 Increasing spending by government on NGS research to augment market 196
TABLE 229 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 197
TABLE 230 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 197
TABLE 231 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 198
TABLE 232 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 198
TABLE 233 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 199
TABLE 234 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 235 SOUTH KOREA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 200
12.4.6 REST OF ASIA PACIFIC 200
TABLE 236 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 200
TABLE 237 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 201
TABLE 238 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 201
TABLE 239 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 201
TABLE 240 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 202
TABLE 241 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 242 REST OF ASIA PACIFIC: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 203
12.4.7 ASIA PACIFIC: IMPACT OF RECESSION 203
12.5 LATIN AMERICA 203
TABLE 243 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 204
TABLE 244 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 204
TABLE 245 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 204
TABLE 246 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 205
TABLE 247 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 205
TABLE 248 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 206
TABLE 249 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 250 LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 207
12.5.1 BRAZIL 207
12.5.1.1 Rising focus on clinical genomics to drive demand for NGS 207
TABLE 251 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 208
TABLE 252 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 208
TABLE 253 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 209
TABLE 254 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 209
TABLE 255 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 209
TABLE 256 BRAZIL: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 257 BRAZIL: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 210
12.5.2 MEXICO 210
12.5.2.1 Growing biotechnology infrastructure development to support market 210
TABLE 258 MEXICO: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 211
TABLE 259 MEXICO: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 211
TABLE 260 MEXICO: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 212
TABLE 261 MEXICO: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 212
TABLE 262 MEXICO: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 212
TABLE 263 MEXICO: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 264 MEXICO: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 213
12.5.3 REST OF LATIN AMERICA 213
TABLE 265 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 214
TABLE 266 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 214
TABLE 267 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 214
TABLE 268 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 215
TABLE 269 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 215
TABLE 270 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 271 REST OF LATIN AMERICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 216
12.5.4 LATIN AMERICA: IMPACT OF RECESSION 216
12.6 MIDDLE EAST & AFRICA 217
12.6.1 INTRODUCTION OF COST-EFFECTIVE AND PORTABLE NGS TECHNOLOGIES TO STIMULATE MARKET 217
TABLE 272 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 217
TABLE 273 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY WORKFLOW, 2021–2028 (USD MILLION) 218
TABLE 274 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 218
TABLE 275 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY METHOD, 2021–2028 (USD MILLION) 218
TABLE 276 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 219
TABLE 277 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 278 MIDDLE EAST & AFRICA: NGS SAMPLE PREPARATION MARKET, BY END USER, 2021–2028 (USD MILLION) 220
13 COMPETITIVE LANDSCAPE 221
13.1 INTRODUCTION 221
13.2 KEY STRATEGIES ADOPTED BY MARKET PLAYERS 221
TABLE 279 NGS SAMPLE PREPARATION MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 222
13.3 REVENUE SHARE ANALYSIS (TOP 5 PLAYERS) 226
FIGURE 31 REVENUE ANALYSIS FOR TOP 5 COMPANIES (2019−2021) 226
13.4 MARKET SHARE ANALYSIS (2022) 227
FIGURE 32 NGS SAMPLE PREPARATION MARKET: MARKET SHARE ANALYSIS OF TOP 5 PLAYERS (2022) 227
13.5 COMPANY EVALUATION QUADRANT 228
FIGURE 33 NGS SAMPLE PREPARATION MARKET: COMPANY EVALUATION MATRIX (2022) 229
13.5.1 STARS 230
13.5.2 EMERGING LEADERS 230
13.5.3 PERVASIVE PLAYERS 230
13.5.4 PARTICIPANTS 230
13.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES 230
13.6.1 PROGRESSIVE COMPANIES 230
13.6.2 STARTING BLOCKS 230
13.6.3 RESPONSIVE COMPANIES 231
13.6.4 DYNAMIC COMPANIES 231
FIGURE 34 NGS SAMPLE PREPARATION MARKET: START-UPS/SMES EVALUATION QUADRANT (2022) 231
13.7 COMPETITIVE BENCHMARKING 232
13.7.1 DETAILED LIST OF START-UPS/SMES 232
TABLE 280 NGS SAMPLE PREPARATION MARKET: DETAILED LIST OF START-UPS/SMES 232
13.7.2 COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES) 233
TABLE 281 NGS SAMPLE PREPARATION MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES] 233
13.8 COMPETITIVE SCENARIO AND TRENDS 234
13.8.1 KEY DEALS 234
TABLE 282 NGS SAMPLE PREPARATION MARKET: KEY DEALS 234
13.8.2 KEY PRODUCT LAUNCHES 239
TABLE 283 NGS SAMPLE PREPARATION MARKET: KEY PRODUCT LAUNCHES 239
13.8.3 KEY EXPANSIONS 240
TABLE 284 NGS SAMPLE PREPARATION MARKET: KEY EXPANSIONS 240

14 COMPANY PROFILES 241
14.1 KEY PLAYERS 241
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 ILLUMINA, INC. 241
TABLE 285 ILLUMINA, INC.: COMPANY OVERVIEW 241
FIGURE 35 ILLUMINA, INC.: COMPANY SNAPSHOT (2021) 242
14.1.2 THERMO FISHER SCIENTIFIC INC. 247
TABLE 286 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 247
14.1.3 F. HOFFMANN-LA ROCHE LTD. 254
TABLE 287 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 254
14.1.4 PERKINELMER INC. 258
TABLE 288 PERKINELMER INC.: COMPANY OVERVIEW 258
FIGURE 38 PERKINELMER INC.: COMPANY SNAPSHOT (2022) 259
14.1.5 AGILENT TECHNOLOGIES, INC. 261
TABLE 289 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 261
14.1.6 DANAHER 266
TABLE 290 DANAHER: COMPANY OVERVIEW 266
14.1.7 BECTON, DICKINSON AND COMPANY 269
TABLE 291 BECTON, DICKINSON, AND COMPANY: COMPANY OVERVIEW 269
FIGURE 41 BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT (2021) 270
14.1.8 QIAGEN 271
TABLE 292 QIAGEN: COMPANY OVERVIEW 271
FIGURE 42 QIAGEN: COMPANY SNAPSHOT (2021) 272
14.1.9 MERCK KGAA 275
TABLE 293 MERCK KGAA: COMPANY OVERVIEW 275
FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT (2021) 276
14.1.10 BIO-RAD LABORATORIES, INC. 278
TABLE 294 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 278
FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021) 279
14.1.11 PROMEGA CORPORATION 280
TABLE 295 PROMEGA CORPORATION: COMPANY OVERVIEW 280
14.1.12 EUROFINS SCIENTIFIC 281
TABLE 296 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 281
FIGURE 45 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021) 281
14.1.13 BGI 283
TABLE 297 BGI: COMPANY OVERVIEW 283
14.1.14 10X GENOMICS 285
TABLE 298 10X GENOMICS: COMPANY OVERVIEW 285
FIGURE 46 10X GENOMICS: COMPANY SNAPSHOT (2021) 285
14.1.15 SYSMEX CORPORATION 287
TABLE 299 SYSMEX CORPORATION: COMPANY OVERVIEW 287
FIGURE 47 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022) 287
14.2 OTHER PLAYERS 289
14.2.1 PSOMAGEN 289
14.2.2 ZYMO RESEARCH CORPORATION 289
14.2.3 TAKARA BIO INC. 290
14.2.4 NOVOGENE CO., LTD. 290
14.2.5 NEW ENGLAND BIOLABS 291
14.2.6 TECAN TRADING AG 291
14.2.7 OXFORD NANOPORE TECHNOLOGIES PLC 292
14.2.8 PACBIO 292
14.2.9 MEDGENOME 293
14.2.10 SWIFT BIOSCIENCES INC. 293
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 DISCUSSION GUIDE 294
15.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 298
15.2 CUSTOMIZATION OPTIONS 300
15.3 RELATED REPORTS 300
15.4 AUTHOR DETAILS 301